VIDEORELAZIONI DELL’ 8th International congress – glucocorticoid induced osteoporosis and other drugh-induced osteoporosis

VIDEORELAZIONI DELL’ 8th International congress – glucocorticoid induced osteoporosis and other drugh-induced osteoporosis

Vai alle videorelazioni

logo gio

Venerdì 31 maggio 2013

C. Marcocci  Commemorazione10:30 – 11:00 Opening Ceremony

11:00 – 13:00 New Insights in the Pathogenesis of GIOR.

V. Thakker  A Mouse Model of Cushing´s Syndrome

M. Schuller Almeida Role of the Oxidative Stress

14:00 – 16:00 Drug-induced Osteoporosis

J. R. Adachi Proton Pump Inhibitors and H2 Receptor Antagonists

O. Bruyère SSRA and Fractures: an Epidemiologic Perspective

G. Mazziotti Cardiovascular Drugs

C. Torti Antiretroviral Therapy

16:30 – 18:00 Malignancy and Osteoporosis

R. Rizzoli  Aromatase Inhibitors and Breast Cancer

C. Marcocci Thyroid Cancer and Levothyroxine Therapy

18:00 – 19:00 Oral Communications

L. Carli Prevalence of reduced bone mineral density and fragility fractures in patients with Systemic Lupus Erythematosus.

L. Carli Analysis of the adherence to the recommendations for the monitoring of glucocorticoids induced osteoporosis in a monocentric cohort of patients with systemic lupus erythematosus.

M. Mazzantini Vertebroplasty in GOP.

C. Tani Spontaneous Adipogenesis in Bone Marrow Derived Mesenchymal Stromal Cells After Chronic Treatment with Glucocorticoids

G. Mazziotti ROLE OF BONE MINERAL DENSITY IN PREDICTING MORPHOMETRIC VERTEBRAL FRACTURES IN PATIENTS WITH HIV INFECTION

L. Manetti Effect of subclinical Cushing’s syndrome on bone mineral density

G. Mazziotti RELANTIONSHIP BETWEEN DIABETES MELLITUS AND SKELETAL FRAGILITY IN PATIENTS EXPOSED TO GLUCOCORTICOID EXCESS

sabato 01 giugno 20130

8:30 – 11:00 Rheumatic and Metabolic Bone Diseases

A. Tincani Systemic Lupus, Autoimmunity and Bone

O. Di Munno Biologics and Bone Remodeling in Rheumatoid Arthritis

L. Hofbauer Osteporotic Fractures in Diabetes Mellitus

S. Giannini Organ Transplantation and Osteoporosis

I. Chiodini Subclinical Hypercortisolism and Bone

11:30 – 13:00 Novel Glucocorticoids

M. Rauner Selective GC Receptor Agonists

R. Alten Modified Release Glucocorticoids

A. Nillson Dual-release Hydrocortisone

14:00 – 15:30 Guidelines and Algorithms

S. R. Goldring Debate, New ACR vs IOF Guidelines in the Management of GIO: Which One to Follow? ACR Guidelines

15:30 – 17:00 Treatment

I. Bertoldi Clodronate

A. Giustina Medical Therapy of Cushing´s Disease

J. P. Bilezikian GIO

17:00 – 17:30 Closing Remark